Ein Arzt berät einen Patienten (Symbolbild).
Mittwoch, 09.01.2019 21:25 von | Aufrufe: 63

WEISSLAW LLP: MedEquities Realty Trust, Inc. Acquisition May Not Be In The Best Interests of MRT Shareholders

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

NEW YORK, Jan. 9, 2019 /PRNewswire/ -- WeissLaw LLP  is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of MedEquities Realty Trust, Inc. ("MRT" or the "Company") (NYSE: MRT) in connection with the proposed acquisition of the Company by Omega Healthcare Investors Inc. ("OHI").  Under the terms of the acquisition agreement, shareholders will be entitled to receive 0.235 shares of OHI and $2.00 in cash for each MRT share they own.  This represents consideration of $9.97 per MRT share, based on OHI's closing price of $33.95 on January 2, the day of the acquisition announcement.

If you own MRT shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Or follow us on Twitter @MarketsAlert

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

WeissLaw is investigating whether MRT's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target price of $12.00 per MRT share.  In addition, prior to the acquisition announcement, MRT shares traded for $11.85 per share, or nearly $2.00 above the per-share consideration. 


ARIVA.DE Börsen-Geflüster

Kurse

Moreover, the acquisition will expand and diversify OHI's portfolio to include new high quality assets types from MRT's portfolio that, according to OHI's CEO, which will "provide [OHI] with meaningful growth opportunities." 

Given these facts, WeissLaw is concentrating its investigation on whether MRT's Board conducted a fair process in agreeing to the proposed acquisition, whether the proposed acquisition undervalues the Company, and whether all material information related to the proposed acquisition is fully and fairly disclosed.      

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-medequities-realty-trust-inc-acquisition-may-not-be-in-the-best-interests-of-mrt-shareholders-300775866.html

SOURCE WeissLaw LLP

Werbung

Mehr Nachrichten zur MORTONS REST. GRP (NEW) Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.